Applications of selected cells in immunohematology in a developing country: case studies

When an antibody is detected, its specificity should be determined and its likely clinical significance should be assessed. When one antibody has been identified, it becomes necessary to confirm the presence of additional significant antibodies to ensure that compatible blood is provided to the pati...

Full description

Saved in:
Bibliographic Details
Published inImmunohematology Vol. 33; no. 1; p. 27
Main Authors Dara, Ravi C, Tiwari, Aseem K, Arora, Dinesh, Mitra, Subhasis, Aggarwal, Geet, Acharya, Devi P, Bhardwaj, Gunjan
Format Journal Article
LanguageEnglish
Published United States 01.01.2017
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:When an antibody is detected, its specificity should be determined and its likely clinical significance should be assessed. When one antibody has been identified, it becomes necessary to confirm the presence of additional significant antibodies to ensure that compatible blood is provided to the patient. To perform this confirmation, specific reagent red blood cells (RBCs) are selected; these are called selected cells. Though the most common use of selected cells is for antibody confirmation, they can also be used for several other immunohematologic applications. In a developing country like India, the performance of antibody screening for unexpected antibodies on a routine basis is a comparatively new phenomenon, and those laboratories performing advanced immunohematologic testing would need to use selected cells to arrive at an accurate conclusion. This report defines selected cells and enumerates sources of these RBCs. Detailed immunohematologic applications are discussed with applicable case studies.
ISSN:0894-203X
DOI:10.21307/immunohematology-2019-006